vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and TENNANT CO (TNC). Click either name above to swap in a different company.
TENNANT CO is the larger business by last-quarter revenue ($291.6M vs $168.4M, roughly 1.7× Esperion Therapeutics, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -11.3%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -3.2%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
The Tennant Company (TNC:NYQ) is a company with about 4000 employees that provides cleaning products. It is a company that is listed in the New York Stock Exchange.
ESPR vs TNC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $291.6M |
| Net Profit | — | $-4.4M |
| Gross Margin | — | 34.6% |
| Operating Margin | 50.6% | -1.4% |
| Net Margin | — | -1.5% |
| Revenue YoY | 143.7% | -11.3% |
| Net Profit YoY | — | -166.7% |
| EPS (diluted) | $0.32 | $-0.21 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $291.6M | ||
| Q3 25 | $87.3M | $303.3M | ||
| Q2 25 | $82.4M | $318.6M | ||
| Q1 25 | $65.0M | $290.0M | ||
| Q4 24 | $69.1M | $328.9M | ||
| Q3 24 | $51.6M | $315.8M | ||
| Q2 24 | $73.8M | $331.0M | ||
| Q1 24 | $137.7M | $311.0M |
| Q4 25 | — | $-4.4M | ||
| Q3 25 | $-31.3M | $14.9M | ||
| Q2 25 | $-12.7M | $20.2M | ||
| Q1 25 | $-40.5M | $13.1M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $-29.5M | $20.8M | ||
| Q2 24 | $-61.9M | $27.9M | ||
| Q1 24 | $61.0M | $28.4M |
| Q4 25 | — | 34.6% | ||
| Q3 25 | — | 42.7% | ||
| Q2 25 | — | 42.1% | ||
| Q1 25 | — | 41.4% | ||
| Q4 24 | — | 41.3% | ||
| Q3 24 | — | 42.4% | ||
| Q2 24 | — | 43.1% | ||
| Q1 24 | — | 44.2% |
| Q4 25 | 50.6% | -1.4% | ||
| Q3 25 | -11.4% | 7.4% | ||
| Q2 25 | 8.6% | 9.6% | ||
| Q1 25 | -34.0% | 6.8% | ||
| Q4 24 | -6.4% | 2.3% | ||
| Q3 24 | -31.0% | 9.7% | ||
| Q2 24 | 3.5% | 11.7% | ||
| Q1 24 | 52.5% | 12.1% |
| Q4 25 | — | -1.5% | ||
| Q3 25 | -35.9% | 4.9% | ||
| Q2 25 | -15.4% | 6.3% | ||
| Q1 25 | -62.2% | 4.5% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | -57.2% | 6.6% | ||
| Q2 24 | -83.9% | 8.4% | ||
| Q1 24 | 44.3% | 9.1% |
| Q4 25 | $0.32 | $-0.21 | ||
| Q3 25 | $-0.16 | $0.80 | ||
| Q2 25 | $-0.06 | $1.08 | ||
| Q1 25 | $-0.21 | $0.69 | ||
| Q4 24 | $-0.14 | $0.35 | ||
| Q3 24 | $-0.15 | $1.09 | ||
| Q2 24 | $-0.33 | $1.45 | ||
| Q1 24 | $0.34 | $1.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | — |
| Total DebtLower is stronger | — | $273.2M |
| Stockholders' EquityBook value | $-302.0M | $601.6M |
| Total Assets | $465.9M | $1.3B |
| Debt / EquityLower = less leverage | — | 0.45× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | — | ||
| Q3 25 | $92.4M | — | ||
| Q2 25 | $86.1M | — | ||
| Q1 25 | $114.6M | — | ||
| Q4 24 | $144.8M | — | ||
| Q3 24 | $144.7M | — | ||
| Q2 24 | $189.3M | — | ||
| Q1 24 | $226.6M | — |
| Q4 25 | — | $273.2M | ||
| Q3 25 | — | $238.3M | ||
| Q2 25 | — | $213.4M | ||
| Q1 25 | — | $213.3M | ||
| Q4 24 | — | $198.2M | ||
| Q3 24 | — | $208.6M | ||
| Q2 24 | — | $205.6M | ||
| Q1 24 | — | $207.4M |
| Q4 25 | $-302.0M | $601.6M | ||
| Q3 25 | $-451.4M | $640.9M | ||
| Q2 25 | $-433.5M | $651.9M | ||
| Q1 25 | $-426.2M | $624.4M | ||
| Q4 24 | $-388.7M | $620.8M | ||
| Q3 24 | $-370.2M | $647.2M | ||
| Q2 24 | $-344.2M | $624.6M | ||
| Q1 24 | $-294.3M | $614.6M |
| Q4 25 | $465.9M | $1.3B | ||
| Q3 25 | $364.0M | $1.3B | ||
| Q2 25 | $347.1M | $1.2B | ||
| Q1 25 | $324.0M | $1.2B | ||
| Q4 24 | $343.8M | $1.2B | ||
| Q3 24 | $314.1M | $1.2B | ||
| Q2 24 | $352.3M | $1.2B | ||
| Q1 24 | $373.1M | $1.2B |
| Q4 25 | — | 0.45× | ||
| Q3 25 | — | 0.37× | ||
| Q2 25 | — | 0.33× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.32× | ||
| Q3 24 | — | 0.32× | ||
| Q2 24 | — | 0.33× | ||
| Q1 24 | — | 0.34× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $14.2M |
| Free Cash FlowOCF − Capex | — | $9.7M |
| FCF MarginFCF / Revenue | — | 3.3% |
| Capex IntensityCapex / Revenue | 0.0% | 1.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $14.2M | ||
| Q3 25 | $-4.3M | $28.7M | ||
| Q2 25 | $-31.4M | $22.5M | ||
| Q1 25 | $-22.6M | $-400.0K | ||
| Q4 24 | $-35.0M | $37.5M | ||
| Q3 24 | $-35.3M | $30.7M | ||
| Q2 24 | $-7.2M | $18.6M | ||
| Q1 24 | $53.8M | $2.9M |
| Q4 25 | — | $9.7M | ||
| Q3 25 | — | $22.3M | ||
| Q2 25 | — | $18.7M | ||
| Q1 25 | — | $-7.4M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | $-35.5M | $26.4M | ||
| Q2 24 | $-7.3M | $14.4M | ||
| Q1 24 | $53.8M | $-100.0K |
| Q4 25 | — | 3.3% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | — | 5.9% | ||
| Q1 25 | — | -2.6% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | -68.7% | 8.4% | ||
| Q2 24 | -9.9% | 4.4% | ||
| Q1 24 | 39.0% | -0.0% |
| Q4 25 | 0.0% | 1.5% | ||
| Q3 25 | 0.0% | 2.1% | ||
| Q2 25 | 0.0% | 1.2% | ||
| Q1 25 | 0.0% | 2.4% | ||
| Q4 24 | 0.0% | 2.9% | ||
| Q3 24 | 0.3% | 1.4% | ||
| Q2 24 | 0.1% | 1.3% | ||
| Q1 24 | 0.1% | 1.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.93× | ||
| Q2 25 | — | 1.11× | ||
| Q1 25 | — | -0.03× | ||
| Q4 24 | — | 5.68× | ||
| Q3 24 | — | 1.48× | ||
| Q2 24 | — | 0.67× | ||
| Q1 24 | 0.88× | 0.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
TNC
| Equipment Sales | $165.5M | 57% |
| Parts And Consumables | $69.1M | 24% |
| Service And Other | $57.0M | 20% |
